HDAC9 and cancer: Elevated levels of HDACs in tumor cells lead to aberrant histone deacetylation, resulting in the silencing of genes essential for correct cell differentiation and growth; in addition, HDAC inhibitors can mediate the induction of a variety of cell death mechanisms, which correlate to the anti-cancer activity in several cancer cell models [12].